Retrospective study evaluating the variability in erlotinib trough concentration and its relationship with the severity of skin rash and diarrhea in non small cell lung cancer patients
Latest Information Update: 29 Aug 2019
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
Most Recent Events
- 29 Aug 2019 New trial record